Market Overview

Mereo Biopharma shares are trading higher after the company announced a successful type B meeting with the FDA and outlined accelerated approval pathway for its Navicixizumab in advanced ovarian cancer.


This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Posted-In: WIIM Markets


Related Articles (MREO)

Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo

5 Things A Great Real Estate Agent Does

M1 Finance Reaches 100K Funded Accounts, Prepares To Launch Banking Feature: 'The Comprehensiveness Of The Platform Makes It Unique'